TATVA CHINTAN PHARMA CHEM
|
|
BOM : 543321     NSE : TATVA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : NA |
Dec 05,2024 |
Price(EOD): ₹ 890.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 2,084.47 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
TATVA CHINTAN PHARMA CHEM | 0.7% | 4% | -42.9% |
PIDILITE INDUSTRIES | 4% | 2.1% | 25.2% |
SOLAR INDUSTRIES INDIA | 1.3% | 9.4% | 72.4% |
SRF | 2.5% | 3.3% | -3.2% |
GUJARAT FLUOROCHEMICALS | 7.6% | 0.2% | 42.5% |
DEEPAK NITRITE | -0.6% | 2.4% | 21.7% |
TATA CHEMICALS | 2.4% | 1.1% | 16.1% |
GODREJ INDUSTRIES | 0.5% | 5% | 65.9% |
AARTI INDUSTRIES | 0.2% | -11.1% | -19.1% |
FUNDAMENTAL ANALYSIS OF TATVA CHINTAN PHARMA CHEM
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TATVA CHINTAN PHARMA CHEM
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
118.3
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 17.61 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 2.83
P/B Calculated based on Book Value of Rs 737.08 Cr
[Latest Year - Mar2024 - Consolidated Results ] 5.61
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 371.43 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 11857% -41% |
SHARE PRICE MOMENTUM OF TATVA CHINTAN PHARMA CHEM
TATVA CHINTAN PHARMA CHEM vs SENSEX
DEBT OF TATVA CHINTAN PHARMA CHEM
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.02 0.34 0.26 0.21 |
0.02 0.33 0.25 0.2 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF TATVA CHINTAN PHARMA CHEM
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF TATVA CHINTAN PHARMA CHEM
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-20.84% -55.71% -115% -112.75% |
-13.63% -72.41% -109.11% -108.53% |
QtrlyTrend |
-8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
TATVA CHINTAN PHARMA CHEM related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE BASIC MATERIALS | 4.3% | 0.6% | 28.5% |
S&P BSE SMALL CAP | 3.5% | 2% | 40.5% |
S&P BSE MIDSMALLCAP | 3.4% | 3% | 40.6% |
S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
You may also like the below Video Courses
FAQ about TATVA CHINTAN PHARMA CHEM
Is TATVA CHINTAN PHARMA CHEM good for long term investment?
As on Dec 05,2024, the Fundamentals of TATVA CHINTAN PHARMA CHEM look Strong and hence it may be good for long term investment! See Financial Performance of TATVA CHINTAN PHARMA CHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TATVA CHINTAN PHARMA CHEM UnderValued or OverValued?
As on Dec 05,2024, TATVA CHINTAN PHARMA CHEM is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of TATVA CHINTAN PHARMA CHEM ?
As on Dec 05,2024, the Intrinsic Value of TATVA CHINTAN PHARMA CHEM is Rs. 753.03 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -0.15
Fair Value [Median EV / Sales Model] : Rs. 7.45
Fair Value [Median Price / Sales Model] : Rs. 1,498.60
Estimated Median Fair Value of TATVA CHINTAN PHARMA CHEM : Rs. 753.03
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is TATVA CHINTAN PHARMA CHEM trading at a Premium or Discount?
As on Dec 05,2024, TATVA CHINTAN PHARMA CHEM is trading at a Premium of 18% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs TATA CHEMICALS LTD